Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27264270 | 0.74 | — | — | |
| SCHEMBL12368445 | 0.69 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL14226110 | 0.67 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL3678363 | 0.61 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL27003510 | 0.61 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL9077911 | 0.60 | — | — | |
| Hydrochloric Acid SCHEMBL2509356 | 0.59 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| Bromide SCHEMBL2511004 | 0.59 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| Bromide SCHEMBL2511005 | 0.59 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL797119 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233438-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | MERIAL INC. (US) | 2017-08-17 | — | — | US | disclosed |
| US-20170022253-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | MERIAL INC. (US) | 2017-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022253-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | ALDH1A1 3037/4885SMN1; SMN2 4620/4885 |
| US-20170233438-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | ALDH1A1 2890/4885SMN1; SMN2 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.